SCHEMBL4148300

SCHEMBL4148300

CN(C(=O)NC(=O)c1c(F)cccc1F)c1ccc(SC(F)F)cc1F

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.45
RAB9A P51151 6/20 0.40
NPC1 O15118 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
HTT P42858 1/20 0.34
RORC P51449 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
PPIA P62937 1/20 0.33
PKM P14618 1/20 0.32
TRPA1 O75762 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4145134 0.91 ATM (0.43) ATMRAB9ANPC1SMN1; SMN2LMNA
SCHEMBL4142542 0.90 ATM (0.42) ATMRAB9ANPC1SMN1; SMN2LMNA
SCHEMBL4154199 0.87 RAB9A (0.38) ATMRAB9ANPC1SMN1; SMN2HTT
SCHEMBL4145038 0.84 ATM (0.35) ATMRAB9ANPC1SMN1; SMN2RORC
SCHEMBL4157453 0.84 TRPA1 (0.36) ATMRAB9ANPC1RORCMEN1
SCHEMBL4158996 0.84 TRPA1 (0.34) ATMRAB9ANPC1LMNAMAPK1
SCHEMBL4160195 0.83 TRPA1 (0.35) ATMRAB9ANPC1RORCMEN1
SCHEMBL5314175 0.83 ATM (0.40) ATMRAB9ANPC1SMN1; SMN2LMNA
SCHEMBL4158482 0.83 MEN1 (0.39) ATMRORCMEN1KMT2APOLB
SCHEMBL4154118 0.82 L3MBTL1 (0.33) ATMRAB9ANPC1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 ATM 2385/4885RAB9A 642/4885NPC1 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.